The ever expanding spectrum of phenotypic diversity in hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 112, Issue 3, 2013, Pages 463-464

  Rowin, Ethan J ^a   Maron, Martin S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILY; GENE MUTATION; GENETIC SCREENING; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MOLECULAR BIOLOGY; NOTE; PATHOPHYSIOLOGY; PATIENT CARE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SARCOMERE; SUDDEN DEATH; SYSTOLIC DYSFUNCTION;

EID: 84880352639     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.05.045     Document Type: Letter

References (14)

1. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
2. B.J. Maron, M.S. Maron, and C. Semsarian Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives J Am Coll Cardiol 60 2012 705 715
3. R. Alcalai, J.G. Seidman, and C.E. Seidman Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics J Cardiovasc Electrophysiol 19 2008 104 110
4. M.S. Maron, B.J. Maron, C. Harrigan, J. Buros, C.M. Gibson, I. Olivotto, L. Biller, J.R. Lesser, J.E. Udelson, W.J. Manning, and E. Appelbaum Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
5. B.J. Maron, P. Spirito, W.K. Shen, T.S. Haas, F. Formisano, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, T. Lawrenz, G. Boriani, N.A. Estes III, S. Favale, M. Piccininno, S.L. Winters, M. Santini, S. Betocchi, F. Arribas, M.V. Sherrid, G. Buja, C. Semsarian, and P. Bruzzi Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412
6. K.M. Harris, P. Spirito, M.S. Maron, A.G. Zenovich, F. Formisano, J.R. Lesser, S. Mackey-Bojack, W.J. Manning, J.E. Udelson, and B.J. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
7. W.C. Roberts, C. Camille Roberts, J. Mi Ko, P.A. Graybum, A. Tandon, J.J. Kuiper, J.E. Capehart, and S.A. Hall Dramatically different phenotypic expressions of hypertrophic cardiomyopathy in male cousins undergoing cardiac transplantation with identical disease-causing gene mutation Am J Cardiol 111 2013 1818 1822
8. M.S. Maron, I. Olivotto, A.G. Zenovich, M.S. Link, N.G. Pandian, J.T. Kuvin, S. Nistri, F. Cecchi, J.E. Udelson, and B.J. Maron Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239
9. M.S. Maron Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 14 2012 13 20
10. I. Olivotto, B.J. Maron, E. Appelbaum, C.J. Harrigan, C. Salton, C.M. Gibson, J.E. Udelson, C. O'Donnell, J.R. Lesser, W.J. Manning, and M.S. Maron Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy Am J Cardiol 106 2010 261 267
11. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, and C.W. Yancy 2011 ACCF/AHA Guideline for the Diagnosis and treatment of hypertrophic cardiomyopathy a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 58 2011 e212 e260
12. M.S. Maron, B.M. Kalsmith, J.E. Udelson, W. Li, and D. DeNofrio Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 574 579
13. H. Watkins, A. Rosenzweig, D.S. Hwang, T. Levi, W. McKenna, C.E. Seidman, and J.G. Seidman Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy N Engl J Med 326 1992 1108 1114
14. A.P. Landstrom, and M.J. Ackerman Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy Circulation 122 2010 2441 2449 discussion 2450